News Astellas’ kidney transplant rejection treatment approved in US HannahBlake 0 Comment Tokyo-based Astellas Pharma Inc. has announced that the US FDA has approved its drug, Astagraf XL, which is Share X Astellas’ kidney transplant rejection treatment approved in US https://pharmaphorum.com/news/astellas-kidney-transplant-rejection-treatment-approved-in-us/
News Bayer donates antibiotic to Zanzibar HannahBlake 0 Comment Bayer Healthcare has donated enough of one of its antibiotics to improve healthcare for as many as 40,000 Share X Bayer donates antibiotic to Zanzibar https://pharmaphorum.com/news/bayer-donates-antibiotic-to-zanzibar/
News Janssen’s RA drug approved in US HannahBlake 0 Comment Janssen Biotech’s rheumatoid arthritis treatment, Simponi Aria (golimumab), has been approved for use in combination with methotrexate in Share X Janssen’s RA drug approved in US https://pharmaphorum.com/news/janssen-s-ra-drug-approved-in-us/
News Abbott reports healthy Q2 results HannahBlake 0 Comment Abbott Laboratories has reported better-than-expected financial results for the second quarter of 2013, with a reported sales increase Share X Abbott reports healthy Q2 results https://pharmaphorum.com/news/abbott-reports-healthy-q2-results/
News US FDA grants Alzheimer’s drug fast track status HannahBlake 0 Comment The US Food and Drug Administration has granted Fast Track Designation to Transition Therapeutics’ development program for ELNDOO5, Share X US FDA grants Alzheimer’s drug fast track status https://pharmaphorum.com/news/us-fda-grants-alzheimer-s-drug-fast-track-status/
News Boehringer and EFSD announce first recipients of €2.5 million diabetes funding Rebecca 0 Comment The recipients of the European-wide funding initiative targeted at diabetes research have been announced today by Boehringer Ingelheim Share X Boehringer and EFSD announce first recipients of €2.5 million diabetes funding https://pharmaphorum.com/news/boehringer-and-efsd-announce-first-recipients-of-2-5-million-diabetes-funding/
News Johnson & Johnson announces healthy Q2 results Rebecca 0 Comment Johnson & Johnson has announced sales of $17.9 billion for the second quarter of 2013, which is an Share X Johnson & Johnson announces healthy Q2 results https://pharmaphorum.com/news/johnson-johnson-announce-healthy-q2-results/
News Pfizer’s RA drug, tofacitinib, gains approval in several additional countries Rebecca 0 Comment Pfizer announced yesterday that its rheumatoid arthritis treatment, tofacitinib, has obtained approval for patients with inadequate response to Share X Pfizer’s RA drug, tofacitinib, gains approval in several additional countries https://pharmaphorum.com/news/pfizers-ra-drug-tofacitinib-gains-approval-in-several-additional-countries/
News Abbott to acquire OptiMedica and enter laser-assisted cataract surgery market Rebecca 0 Comment Abbott announced yesterday that it will be acquiring OptiMedica Corporation, a privately held ophthalmic device company. This will Share X Abbott to acquire OptiMedica and enter laser-assisted cataract surgery market https://pharmaphorum.com/news/abbott-to-acquire-optimedica-and-enter-laser-assisted-cataract-surgery-market/
